PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels

Quan Yuan, Despina Sitara, Tadatoshi Sato, Michael Densmore, Hiroaki Saito, Christine Schul̈er, Reinhold G. Erben, Beate Lanske

Research output: Contribution to journalArticle

Abstract

Fibroblast growth factor 23 (FGF23) is a key regulator of mineral ion homeostasis. Genetic ablation of Fgf23 in mice leads to severe biochemical disorders including elevated serum 1,25-dihydroxyvitamin D [1,25(OH) 2D], hypercalcemia, hyperphosphatemia, and marked decreased PTH levels. Because PTH stimulates 1,25(OH) 2D production and increases serum calcium levels, we hypothesized that ablation of PTH from the Fgf23 knockout (Fgf23 -/-) mice could suppress these affects, thus ameliorating the soft tissue and skeletal anomalies in these animals. In this study, we generated a genetic mouse model with dual ablation of the Fgf23/PTH genes. The data show that deletion of PTH does suppress the markedly higher serum 1,25(OH) 2D and calcium levels observed in Fgf23 -/- mice and results in much larger, heavier, and more active double-knockout mice with improved soft tissue and skeletal phenotypes. On the contrary, when we infused PTH (1-34) peptide into Fgf23 -/- mice using osmotic minipumps, serum 1,25(OH) 2D and calcium levels were increased even further, leading to marked reduction in trabecular bone. These results indicate that PTH is able to modulate the anomalies of Fgf23 -/- mice by controlling serum 1,25(OH) 2D and calcium levels.

Original languageEnglish (US)
Pages (from-to)4053-4061
Number of pages9
JournalEndocrinology
Volume152
Issue number11
DOIs
StatePublished - Nov 2011

Fingerprint

Knockout Mice
Vitamin D
Calcium
Serum
Hyperphosphatemia
Genetic Models
Hypercalcemia
Parathyroid Hormone
Minerals
Homeostasis
Ions
Phenotype
Peptides
Genes

ASJC Scopus subject areas

  • Endocrinology

Cite this

PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels. / Yuan, Quan; Sitara, Despina; Sato, Tadatoshi; Densmore, Michael; Saito, Hiroaki; Schul̈er, Christine; Erben, Reinhold G.; Lanske, Beate.

In: Endocrinology, Vol. 152, No. 11, 11.2011, p. 4053-4061.

Research output: Contribution to journalArticle

Yuan, Q, Sitara, D, Sato, T, Densmore, M, Saito, H, Schul̈er, C, Erben, RG & Lanske, B 2011, 'PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels', Endocrinology, vol. 152, no. 11, pp. 4053-4061. https://doi.org/10.1210/en.2011-1113
Yuan, Quan ; Sitara, Despina ; Sato, Tadatoshi ; Densmore, Michael ; Saito, Hiroaki ; Schul̈er, Christine ; Erben, Reinhold G. ; Lanske, Beate. / PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels. In: Endocrinology. 2011 ; Vol. 152, No. 11. pp. 4053-4061.
@article{cfc2db1efc9f4f10a41633c2cab15a11,
title = "PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels",
abstract = "Fibroblast growth factor 23 (FGF23) is a key regulator of mineral ion homeostasis. Genetic ablation of Fgf23 in mice leads to severe biochemical disorders including elevated serum 1,25-dihydroxyvitamin D [1,25(OH) 2D], hypercalcemia, hyperphosphatemia, and marked decreased PTH levels. Because PTH stimulates 1,25(OH) 2D production and increases serum calcium levels, we hypothesized that ablation of PTH from the Fgf23 knockout (Fgf23 -/-) mice could suppress these affects, thus ameliorating the soft tissue and skeletal anomalies in these animals. In this study, we generated a genetic mouse model with dual ablation of the Fgf23/PTH genes. The data show that deletion of PTH does suppress the markedly higher serum 1,25(OH) 2D and calcium levels observed in Fgf23 -/- mice and results in much larger, heavier, and more active double-knockout mice with improved soft tissue and skeletal phenotypes. On the contrary, when we infused PTH (1-34) peptide into Fgf23 -/- mice using osmotic minipumps, serum 1,25(OH) 2D and calcium levels were increased even further, leading to marked reduction in trabecular bone. These results indicate that PTH is able to modulate the anomalies of Fgf23 -/- mice by controlling serum 1,25(OH) 2D and calcium levels.",
author = "Quan Yuan and Despina Sitara and Tadatoshi Sato and Michael Densmore and Hiroaki Saito and Christine Schul̈er and Erben, {Reinhold G.} and Beate Lanske",
year = "2011",
month = "11",
doi = "10.1210/en.2011-1113",
language = "English (US)",
volume = "152",
pages = "4053--4061",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "11",

}

TY - JOUR

T1 - PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels

AU - Yuan, Quan

AU - Sitara, Despina

AU - Sato, Tadatoshi

AU - Densmore, Michael

AU - Saito, Hiroaki

AU - Schul̈er, Christine

AU - Erben, Reinhold G.

AU - Lanske, Beate

PY - 2011/11

Y1 - 2011/11

N2 - Fibroblast growth factor 23 (FGF23) is a key regulator of mineral ion homeostasis. Genetic ablation of Fgf23 in mice leads to severe biochemical disorders including elevated serum 1,25-dihydroxyvitamin D [1,25(OH) 2D], hypercalcemia, hyperphosphatemia, and marked decreased PTH levels. Because PTH stimulates 1,25(OH) 2D production and increases serum calcium levels, we hypothesized that ablation of PTH from the Fgf23 knockout (Fgf23 -/-) mice could suppress these affects, thus ameliorating the soft tissue and skeletal anomalies in these animals. In this study, we generated a genetic mouse model with dual ablation of the Fgf23/PTH genes. The data show that deletion of PTH does suppress the markedly higher serum 1,25(OH) 2D and calcium levels observed in Fgf23 -/- mice and results in much larger, heavier, and more active double-knockout mice with improved soft tissue and skeletal phenotypes. On the contrary, when we infused PTH (1-34) peptide into Fgf23 -/- mice using osmotic minipumps, serum 1,25(OH) 2D and calcium levels were increased even further, leading to marked reduction in trabecular bone. These results indicate that PTH is able to modulate the anomalies of Fgf23 -/- mice by controlling serum 1,25(OH) 2D and calcium levels.

AB - Fibroblast growth factor 23 (FGF23) is a key regulator of mineral ion homeostasis. Genetic ablation of Fgf23 in mice leads to severe biochemical disorders including elevated serum 1,25-dihydroxyvitamin D [1,25(OH) 2D], hypercalcemia, hyperphosphatemia, and marked decreased PTH levels. Because PTH stimulates 1,25(OH) 2D production and increases serum calcium levels, we hypothesized that ablation of PTH from the Fgf23 knockout (Fgf23 -/-) mice could suppress these affects, thus ameliorating the soft tissue and skeletal anomalies in these animals. In this study, we generated a genetic mouse model with dual ablation of the Fgf23/PTH genes. The data show that deletion of PTH does suppress the markedly higher serum 1,25(OH) 2D and calcium levels observed in Fgf23 -/- mice and results in much larger, heavier, and more active double-knockout mice with improved soft tissue and skeletal phenotypes. On the contrary, when we infused PTH (1-34) peptide into Fgf23 -/- mice using osmotic minipumps, serum 1,25(OH) 2D and calcium levels were increased even further, leading to marked reduction in trabecular bone. These results indicate that PTH is able to modulate the anomalies of Fgf23 -/- mice by controlling serum 1,25(OH) 2D and calcium levels.

UR - http://www.scopus.com/inward/record.url?scp=80054930335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054930335&partnerID=8YFLogxK

U2 - 10.1210/en.2011-1113

DO - 10.1210/en.2011-1113

M3 - Article

C2 - 21896668

AN - SCOPUS:80054930335

VL - 152

SP - 4053

EP - 4061

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 11

ER -